The UAE will host Expo 2020!
  • Arabic
Supported by the UAE National Media Council
We are in the process of developing and improving our website, and we invite you to participate in our brief survey to measure the level of your satisfaction
Satisfaction Survey For UAE Interact Website
رغبة منا بالتعرف على مستوى رضاكم عن موقعنا وبهدف تطويره وتحسينه، فقد قمنا بتصميم استبيان سريع لقياس مدى الرضا عن موقع دولة الإمارات العربية المتحدة روعي في تصميم الاستبيان أن يكون قصيرا وسريعا كي لا نطيل عليكم، وعليه نرجو منكم التكرم باستكماله عن طريق الرابط التالي
استبيان رضا المتعاملين عن موقع دولة الإمارات العربية المتحدة

Antivenin from camels to be tested in Africa

posted on 18/08/2010: 1933 views

Antivenin developed from camel antibodies will be in use in Africa within two years to treat victims of snake bites, the head of a laboratory in Dubai said yesterday.

Researchers from Britain and the Central Veterinary Research Laboratory (CVRL) in Dubai have collaborated to use camels instead of the more usual horses or sheep as incubators for a new antivenin â€" the antitoxins that counteract specific snake venoms.

Yesterday, the team released the results of the first phase of the research. Camel antibodies were found to be as effective as sheep and horse antivenins. But they are smaller, cheaper and can be stored unrefrigerated, which makes them an attractive alternative.

Around 40 camels were injected with tiny amounts of the toxins from snakes commonly found in Africa â€" the puff adder, the saw-scaled viper and the black spitting cobra.

Over the past six months, the CVRL has extracted about 70 litres of antivenin serum, which will be refined to seven litres of antivenin, enough to treat 1,000 snakebites.

“We’ve shown that we can consistently create high quality antivenin at a certain yield, that the product is biologically active and economically viable,” said Dr Hedwig Reichl, whose Austrian company, Haemosan LSS GmbH, developed the machines to purify the antivenin. “Next, we have to industrialise the collection of it.”

The second phase of the project is clinical trials on mice, which may begin as early as next month, before testing on humans. The CVRL has fitted two rooms with equipment worth Dh3 million to produce the antibodies needed for the antivenin.

“This is just the beginning. We want really to go big, and use the same technology to make vaccines for diseases such as polio, tuberculosis, malaria and even HIV. All of this has real future prospects,” Dr Ulrich Wernery, the scientific director of the CVRL, said. “Maybe someday we’ll have our own institute,” he added.

The study found that while camel-incubated venom was equally effective as horse and sheep-incubated venom, there were some advantages. The team believes that the camel antivenin could create fewer adverse effects.

“This could have potentially huge benefits, but that can only be determined in the clinical trials. Since we’re looking for adverse effects the trials will have to be very big,” said Dr Rob Harrison, the head of the Alistair Reid venom research unit at the Liverpool School of Tropical Medicine, a partner in the project.

Current antivenins frequently cause allergic reactions that can be severe and result in death. But the size of camel antibodies could create a breakthrough treatment. Horse and sheep antibodies are too large to move through the human tissue wall, making them unable to stop the death of living tissue as the toxins from venom spread.

Scientists think that camel antibodies, which are about one-tenth the size of those from horses or sheep, will be able to pass through the tissue wall to prevent the spread.

Antivenin is produced by injecting small amounts of toxin into animals and then harvesting the antibodies, the proteins produced by the immune system to fight viruses, bacteria and venom. Current antivenins need to be kept frozen, which can be challenging in parts of Africa, where most snake-bite fatalities occur but where electricity supplies are unreliable. As a result, treatments have a short shelf life.

Dr Wernery believes that camel antibodies are “special” because of the animal’s ability to survive in harsh environments. Researchers think that the camel antibodies are more resistant to heat, and will be able to be kept at room temperature.

Treatments are prohibitively expensive for many people in rural areas of Africa. With few customers for antivenins, big pharmaceutical companies largely halted production a decade ago. â€" The National


08 May 2017 Sheikh Zayed camel racetrack launched in Morocco
03 January 2017 Umm Al Qaiwain to organise Mohamed bin Zayed Camel Racing Festival next week
03 November 2016 Winners of Sheikh Zayed Camel Race Festival in Jordan crowned
19 May 2016 UAE launches biggest camel racetrack in Africa at Tan-Tan Moussem Festival
17 April 2016 Masdar Institute files patent on student’s innovative system improve camel’s health and racing performance

Most Read